Inventor · disambiguated record
Guo Zhu Zheng
Also filed as: ZHENG GUO Z · ZHENG GUO ZHU
33 granted patents·14 pending applications·213 citations·filing 2001–2025
97Inventor score
Top patents by PatentIndex Score
47 records- 0192US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0292US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0392US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 0491US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 0591US9186367B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2014·Granted Nov 17, 2015·15 cites·14 claims
- 0691US7348343B2Amides useful for treating painABBOTT LAB·Filed 2006·Granted Mar 25, 2008·8 cites·11 claims
- 0789US7576110B2Benzothiazole cyclobutyl amine derivativesABBOTT LAB·Filed 2006·Granted Aug 18, 2009·13 cites·18 claims
- 0889US7129235B2Amides useful for treating painABBOTT LAB·Filed 2004·Granted Oct 31, 2006·32 cites·33 claims
- 0985US9796683B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 24, 2017·6 cites·32 claims
- 1085US6933311B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Aug 23, 2005·24 cites·23 claims
- 1184US9481669B2Pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2015·Granted Nov 1, 2016·7 cites·46 claims
- 1284US9340527B2S1P modulating agentsTHOMAS JERMAINE·Filed 2012·Granted May 17, 2016·6 cites·38 claims
- 1384US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 1482US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 1582US7074805B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2003·Granted Jul 11, 2006·10 cites·69 claims
- 1681US10034869B2S1P modulating agentsBIOGEN MA INC·Filed 2017·Granted Jul 31, 2018·2 cites·18 claims
- 1780US9808449B2S1P modulating agentsBIOGEN MA INC·Filed 2015·Granted Nov 7, 2017·2 cites·21 claims
- 1880US7335678B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptorABBOTT LAB·Filed 2004·Granted Feb 26, 2008·8 cites·12 claims
- 1977US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 2076US10894040B2S1P modulating agentsBIOGEN MA INC·Filed 2019·Granted Jan 19, 2021·0 cites·20 claims
- 2176US7728031B2Octahydro-pyrrolo[3,4-b]pyrrole derivativesABBOTT LAB·Filed 2007·Granted Jun 1, 2010·2 cites·18 claims
- 2276US6831193B2Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·8 cites·68 claims
- 2374US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 2474US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2572US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 2669US6693136B1Fluorenes and anthracenes that inhibit P2X3 and P2X2/3 containing receptorsABBOTT LAB·Filed 2002·Granted Feb 17, 2004·7 cites·25 claims
- 2767US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 2866US2019209592A1Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2965US10406144B2SIP modulating agentsBIOGEN MA INC·Filed 2018·Granted Sep 10, 2019·0 cites·18 claims
- 3065US2008153809A1Novel amides useful for treating painABBOTT LAB·Filed 2008·Application pending·0 cites
- 3164US8247413B2Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorLEE CHIH-HUNG·Filed 2008·Granted Aug 21, 2012·0 cites·10 claims
- 3260US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 3360US8592467B2Benzothiazole cyclobutyl amine derivativesCOWART MARLON D·Filed 2009·Granted Nov 26, 2013·0 cites·14 claims
- 3457US2020361915A1Solid state form of pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 3556US10745387B2Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereofEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·26 claims
- 3655US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 3750US2018141913A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 3850US2020255415A1Tetrasubstituted alkene compounds and their use for the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 3949US10851065B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Granted Dec 1, 2020·0 cites·20 claims
- 4048US2003158188A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2002·Application pending·0 cites
- 4147US8399468B2Octahydro-pyrrolo[3,4-B]pyrrole derivativesCOWART MARLON D·Filed 2010·Granted Mar 19, 2013·0 cites·14 claims
- 4244US2005113576A1Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorFiled 2004·Application pending·0 cites
- 4344US2014275010A1Quaternary saltsZHENG GUO ZHU·Filed 2014·Application pending·0 cites
- 4443US2005009841A1Novel amides useful for treating painFiled 2003·Application pending·0 cites
- 4541US2006189639A1Antagonists of the mGlu receptor and uses thereofSTEWART ANDREW O·Filed 2006·Application pending·0 cites
- 4638US2019337921A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 4737US2002173665A1Trisubstituted-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit P2X3 and P2X2/3 containing receptorsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →